22nd Dec 2011 17:18
For filings with the FSA include the annex | |||||
For filings with issuer exclude the annex | |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Dechra Pharamceuticals Plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | ü | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): | |||||
3. Full name of person(s) subject to thenotification obligation: iii | FMR LLC | ||||
4. Full name of shareholder(s) (if different from 3.):iv | See attached schedule | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 21 December 2011 | ||||
6. Date on which issuer notified: | 22 December 2011 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | 5% | ||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares viii, ix | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | ||||||||||||
Indirect | Direct xi | Indirect xii | Direct | Indirect | ||||||||||||
GB0009633180 | 3,169,167 | 3,169,167 | 3,355,614 | 3,355,614 | 5.04 | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | ||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |||||||||||
Nominal | Delta | |||||||||||||||
Total (A+B+C) | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
3,355,614 | 5.04 | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi | ||
See attached schedule | ||
Proxy Voting: | ||
10. Name of the proxy holder: | FMR LLC | |
11. Number of voting rights proxy holder will acquire: | 186,447 | |
12. Date on which proxy holder will acquire voting rights: | 21 December 2011 | |
13. Additional information: | None | |
14. Contact name: |
Shaheen Hussain
| |
15. Contact telephone number: |
[email protected] / 01737 837149
| |
Note: Annex should only be submitted to the FSA not the issuer | |
Annex: Notification of major interests in sharesxxii | |
A: Identity of the persons or legal entity subject to the notification obligation | |
Full name (including legal form of legal entities)
| FMR LLC |
Contact address (registered office for legal entities)
| 82 Devonshire Street, Boston, MA, 02109 USA |
Phone number & email
| 01737 837148 |
Other useful information (at least legal representative for legal persons)
| Company Secretary |
B: Identity of the notifier, if applicable | |
Full name
| FIL Investments International |
Contact address
| Kingswood Fields, Millfield Lane, Lower Kingswood, Tadworth, Surrey KT20 6RB |
Phone number & email
| 01737 837148 |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) | Authorised to make this filing under power of attorney |
C: Additional information | |
None |
FMR | |||||
FMR | |||||
Issuer name: | DECHRA PHARMACEUTICALS PLC | ||||
Current ownership percentage: | 5.04% | ||||
Total shares held: | 3,355,614 | ||||
Issued share capital: | 66,474,826 | ||||
SHARES HELD | NOMINEE | MANAGEMENT COMPANY | |||
FMR LLC is the parent holding company of Fidelity | 704,530 | BROWN BROTHERS HARRIMAN AND CO | FMRCO | ||
Management & Research Company (FMRCO), investment | 1,446,750 | CITIBANK NA | FMRCO | ||
manager for US mutual funds, FIL Management Trust | 247,100 | NORTHERN TRUST CO | FMRCO | ||
Company (FMTC), Pyramis Global Advisors Trust Company | 951,734 | STATE STREET BANK AND TR CO | FMR | ||
(PGATC), a US state chartered bank which acts as a trustee | 5,500 | STATE STREET BANK AND TR CO | FMRCO | ||
or investment manager of various pension and trust accounts | |||||
Pyramis Global Advisors LLC (PGALLC) and | |||||
Pyramis Trust Company (PTC). |
Related Shares:
DPH.L